Latest News about MDGL
Recent news which mentions MDGL
3 Biotechs That Might Get Bought Out in 2023
April 26, 2023
From Motley Fool
Why Madrigal Pharmaceuticals Stock Gained 20% This Week
April 20, 2023
From Motley Fool
Where Is The Current Bull Market? Scan Of Stocks Gaining Over 20% Over The Past Week Almost Exclusively Yields Biotech Names
April 20, 2023
From Benzinga
5 Best Stocks to Buy in April
April 01, 2023
From Motley Fool
From Motley Fool
Is Viking Therapeutics a Smart Buy on the Dip?
March 27, 2023
From Motley Fool
From InvestorPlace
Tickers
MDGL
From Motley Fool
3 Incredible Growth Stocks to Buy if the Market Dips
March 02, 2023
From Motley Fool
2 Surging Healthcare Stocks That Are Still Worth Buying
February 23, 2023
From Motley Fool
Inside the NASH drug boom: New drugs for a ‘silent’ liver disease that affects millions near FDA approval
February 13, 2023
From MarketWatch
3 Top Healthcare Stocks to Buy for January
January 11, 2023
From Motley Fool
Here's How Much You Would Have Made Owning Madrigal Pharmaceuticals Stock In The Last 5 Years
January 09, 2023
Tickers
MDGL
From Benzinga
5 Most Expensive Health Care Stocks You Should Worry About
January 03, 2023
From Benzinga
Why These 7 Healthcare Stocks Could Soar in 2023
January 02, 2023
Tags
VEEV
Market News
NASDAQ:VRNA,NYSE:INSP,NASDAQ:SDGR,NASDAQ:INCY,NASDAQ:VTRS,NYSE:VEEV,NASDAQ:MDGL
From InvestorPlace
5 Top Stocks for January
January 01, 2023
From Motley Fool
Singing Machine, Blue Apron, Camber Energy And More Short Squeeze Candidates That Could Soar This Week
December 27, 2022
From Benzinga
This Stock That Tripled in 2022 Could Rocket Even Higher in 2023
December 26, 2022
From Motley Fool
Universal Health Services, Madrigal Pharmaceuticals And These Overbought Majors In The Healthcare Sector
December 23, 2022
From Benzinga
Why Madrigal Pharmaceuticals Was a Top Stock This Week
December 23, 2022
Tickers
MDGL
From Motley Fool
7 Drug Stocks That Will Soar in 2023
December 22, 2022
From InvestorPlace
Top M&A Target: Madrigal Pharmaceuticals Could Be Next After Successful NASH Data, Analyst Says
December 20, 2022
From Benzinga
Madrigal Pharmaceuticals Gets Price Target Bumps By Analysts Following Successful NASH Study
December 20, 2022
Tickers
MDGL
From Benzinga
Peering Into Madrigal Pharmaceuticals's Recent Short Interest
December 20, 2022
Tickers
MDGL
From Benzinga
Tesla To $285? Here Are 10 Other Price Target Changes For Tuesday
December 20, 2022
From Benzinga
Here's How An Options Trader Made $5.5 Million In One Day
December 20, 2022
Tickers
MDGL
From Benzinga
Tesla, Amazon, Apple, Madrigal, Walt Disney: Why These 5 Stocks Are Drawing Investors' Attention Today
December 19, 2022
From Benzinga
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.